Genetic sequencing ( DrugBank: - )
2 diseases
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 40 | Takayasu arteritis | 1 |
| 231 | Alpha-1-antitrypsin deficiency | 1 |
40. Takayasu arteritis
Clinical trials : 24 / Drugs : 40 - (DrugBank : 18) / Drug target genes : 23 - Drug target pathways : 110
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT03199183 (ClinicalTrials.gov) | January 1, 2017 | 23/6/2017 | Registration Study of Takayasu's Arteritis in China | Registration Study of Takayasu's Arteritis in China | Takayasu Arteritis | Radiation: PET-CT;Other: laboratory biomarker analysis;Genetic: genetic sequencing | China National Center for Cardiovascular Diseases | NULL | Recruiting | N/A | N/A | All | 1067 | China |
231. Alpha-1-antitrypsin deficiency
Clinical trials : 93 / Drugs : 77 - (DrugBank : 8) / Drug target genes : 10 - Drug target pathways : 36
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT02810327 (ClinicalTrials.gov) | February 2015 | 20/6/2016 | Alpha-1 Carrier Genomics Study | Alpha-1 Carrier Genomics Study | Alpha-1 Antitrypsin Deficiency;Emphysema;COPD;Smoking | Genetic: Genetic Sequencing | Medical University of South Carolina | CSL Behring | Completed | 18 Years | N/A | All | 117 | United States |